Omada Health CEO disposes shares for tax withholding

Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported a tax-related share disposition.

Accepted by SEC EDGAR 03/09/2026 - 07:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported a tax-related share disposition. On March 5, 2026, he disposed of 4,983 shares of common stock at $13.60 per share in a transaction coded as a tax-withholding disposition, leaving 121,661 shares held directly.

He also reports 861,109 shares of common stock held indirectly through family trusts noted in a footnote. These trusts hold shares for the benefit of his family members, and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.

Insider Trade Summary

Exercise Price or Tax Liability: 4,983 shares

Exercise Price or Tax Liability 1 txn

Insider Duffy Sean P.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	4,983	$13.60	$68K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 121,661 shares (Direct); Common Stock — 861,109 shares (Indirect, See footnote)

Holdings Before and After: Common Stock, 126,644 to 121,661 shares (Direct)

Footnotes (1)

1. F1. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) CEO Sean Duffy report?

Sean Duffy reported a tax-withholding disposition of Omada Health common stock. On March 5, 2026, he disposed of 4,983 shares at $13.60 per share in a code F transaction related to covering tax obligations, not an open-market sale.

How many Omada Health (OMDA) shares does the CEO hold after this Form 4?

After the reported transaction, Sean Duffy holds 121,661 Omada Health common shares directly. The Form 4 also lists 861,109 shares held indirectly through family trusts, for which he disclaims beneficial ownership except for his pecuniary interest in those trusts.

Was the Omada Health (OMDA) CEO’s Form 4 a stock sale in the open market?

The Form 4 shows a code F tax-withholding disposition, not an open-market sale. Shares were disposed of to satisfy tax obligations at $13.60 per share, a common mechanism when equity awards vest and generate taxable income for the holder.

What does the indirect ownership in Omada Health (OMDA) family trusts mean?

The Form 4 notes 861,109 shares held in family trusts for Sean Duffy’s family members. A footnote states he disclaims beneficial ownership of those trust-held shares, except for his pecuniary interest, meaning economic benefit he may derive from the trusts.

How many Omada Health (OMDA) shares were involved in the CEO’s tax-withholding transaction?

The tax-withholding disposition involved 4,983 shares of Omada Health common stock. These shares were valued at $13.60 per share and were used to cover tax liabilities associated with equity compensation rather than representing a discretionary open-market stock sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffy Sean P.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		F		4,983	D	$13.6	121,661	D
Common Stock								861,109	I	See footnote(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

	/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.